210 related articles for article (PubMed ID: 26592446)
1. Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
Marjon KD; Termini CM; Karlen KL; Saito-Reis C; Soria CE; Lidke KA; Gillette JM
Oncogene; 2016 Aug; 35(31):4132-40. PubMed ID: 26592446
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin CD82 Regulates the Spatiotemporal Dynamics of PKCα in Acute Myeloid Leukemia.
Termini CM; Lidke KA; Gillette JM
Sci Rep; 2016 Jul; 6():29859. PubMed ID: 27417454
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation.
Floren M; Restrepo Cruz S; Termini CM; Marjon KD; Lidke KA; Gillette JM
Oncogene; 2020 May; 39(19):3910-3925. PubMed ID: 32203165
[TBL] [Abstract][Full Text] [Related]
4. The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density.
Termini CM; Cotter ML; Marjon KD; Buranda T; Lidke KA; Gillette JM
Mol Biol Cell; 2014 May; 25(10):1560-73. PubMed ID: 24623721
[TBL] [Abstract][Full Text] [Related]
5. The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells.
Saito-Reis CA; Marjon KD; Pascetti EM; Floren M; Gillette JM
Mol Biol Cell; 2018 Nov; 29(24):2946-2958. PubMed ID: 30133344
[TBL] [Abstract][Full Text] [Related]
6. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD82 represses Sp1-mediated Snail expression and the resultant E-cadherin expression interrupts nuclear signaling of β-catenin by increasing its membrane localization.
Lee MS; Byun HJ; Lee J; Jeoung DI; Kim YM; Lee H
Cell Signal; 2018 Dec; 52():83-94. PubMed ID: 30189244
[TBL] [Abstract][Full Text] [Related]
8. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
[TBL] [Abstract][Full Text] [Related]
10. A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Abe M; Sugiura T; Takahashi M; Ishii K; Shimoda M; Shirasuna K
Cancer Lett; 2008 Aug; 266(2):163-70. PubMed ID: 18395972
[TBL] [Abstract][Full Text] [Related]
11. CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer.
Ma Z; Gao Y; Liu W; Zheng L; Jin B; Duan B; Xie H; Guo P; Zeng J; Wang K; Xu S; Wang X; He D; Li L
Dis Markers; 2020; 2020():8899924. PubMed ID: 33204367
[TBL] [Abstract][Full Text] [Related]
12. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.
Ono M; Handa K; Withers DA; Hakomori S
Biochem Biophys Res Commun; 2000 Dec; 279(3):744-50. PubMed ID: 11162423
[TBL] [Abstract][Full Text] [Related]
14. CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2014 Jan; 134(1):55-64. PubMed ID: 23797738
[TBL] [Abstract][Full Text] [Related]
15. The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein.
Mazurov D; Heidecker G; Derse D
J Biol Chem; 2007 Feb; 282(6):3896-903. PubMed ID: 17166843
[TBL] [Abstract][Full Text] [Related]
16. CD82 (KAI1), a member of the tetraspan family, is expressed on early haemopoietic progenitor cells and up-regulated in distinct human leukaemias.
Burchert A; Notter M; Dietrich Menssen H; Schwartz S; Knauf W; Neubauer A; Thiel E
Br J Haematol; 1999 Dec; 107(3):494-504. PubMed ID: 10583248
[TBL] [Abstract][Full Text] [Related]
17. CD82 palmitoylation site mutations at Cys5+Cys74 affect EGFR internalization and metabolism through recycling pathway.
Bu J; Zhong W; Li M; He S; Zhang M; Zhang Y; Li Y
Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):400-408. PubMed ID: 35538033
[TBL] [Abstract][Full Text] [Related]
18. Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis.
Bergsma A; Ganguly SS; Dick D; Williams BO; Miranti CK
Bone; 2018 Aug; 113():105-113. PubMed ID: 29782939
[TBL] [Abstract][Full Text] [Related]
19. Targeting CXCR4/SDF-1 axis by lipopolymer complexes of siRNA in acute myeloid leukemia.
Landry B; Gül-Uludağ H; Plianwong S; Kucharski C; Zak Z; Parmar MB; Kutsch O; Jiang H; Brandwein J; Uludağ H
J Control Release; 2016 Feb; 224():8-21. PubMed ID: 26742943
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.
Nishioka C; Ikezoe T; Yokoyama A
Cancer Med; 2015 Sep; 4(9):1426-31. PubMed ID: 26139471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
